Top 10 Global Pharmaceutical Company in 2018
Posted on26 May 2019
Comments0
Roche to launch emicizumab (Hemlibra) in India for people with haemophilia A on World Haemophilia Day
Roche announced that emicizumab (Hemlibra) has been approved in India for haemophilia A with factor VIII inhibitors. It is indicated as a... Read More
Roche receives US FDA approval for Herceptin Hylecta for subcutaneous injection in certain HER2-positive breast cancers
Roche announced that the US Food and Drug Administration (FDA) has approved Herceptin Hylecta (trastuzumab and hyaluronidase-oysk) for subcutaneous (under the skin)... Read More
Roche to acquire U.S.-Based Gene Therapy Specialist Spark @ $4.8 Billion
Swiss drugmaker Roche agreed to buy Philadelphia-based Spark Therapeutics for $4.8 billion. Spark works to create gene therapies for genetic diseases, including... Read More
EMA’s Prime Designation for Roche’s RG6042 – to treat Huntington’s disease
Roche announced that the European Medicines Agency (EMA) has granted Prime (PRIority MEdicines) designation for the company’s investigational medicine RG6042 (formerly known... Read More
Quick look into Roche’s Tecentriq US FDA priority review grant
USFDA has accepted the Roche’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq. (atezolizumab), in combination with Avastin (bevacizumab),... Read More
Cipla – Roche Deal – Cipla will promote and distribute Roche’s tocilizumab and Syndyma in India
Cipla Ltd and Roche Pharma India has entered an agreement under which Cipla will promote and distribute tocilizumab and Syndyma, the 2nd... Read More
USFDA approval of Avastin biosimilar Mvasi
Posted on16 Sep 2017
Comments0
The USFDA is approved a version of Avastin, a blockbuster chemotherapy made by Genentech that brought in $6.7 billion in sales in... Read More
Top 5 global pharmaceutical brands by sales
Observations: All top 5 pharmaceutical brands are biopharma products Harvoni approved by USFDA on Oct 10, 2014. It is one of the... Read More